Navigation Links
Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification

ion label for Flurizan."

About Flurizan(TM)

Myriad has two Phase 3 trials of Flurizan ongoing in patients with mild Alzheimer's disease. In each study, participants are taking 800 mg of Flurizan or placebo twice daily, and participants enrolled will have taken the study drug for 18 months. Flurizan is the first in a new class of drug candidates known as Selective Amyloid beta-42 Lowering Agents (SALAs). Flurizan lowered levels of Abeta42 in cellular assays and animal models. Abeta42 is the primary constituent of senile plaque that accumulates in the brain of patients with Alzheimer's disease. It is thought to be the key initiator of Alzheimer's disease, since Abeta42 has the greatest tendency to aggregate, cause neuronal damage and initiate amyloid deposits in the brain. Most genetic mutations that cause early-onset Alzheimer's disease appear to do so by increasing production of Abeta42. Myriad believes that Flurizan is the most advanced drug candidate that modifies the production of Abeta42 to be evaluated in a clinical trial for the treatment of Alzheimer's disease.

About Myriad

Myriad Genetics, Inc. is a biopharmaceutical company focused on the development and marketing of novel healthcare products. The Company develops and markets molecular diagnostic products, and is developing and intends to market therapeutic products. Myriad's news and other information are available on the Company's Web site at www.myriad.com. Flurizan is a trademark of Myriad Genetics, Inc. in the United States and other countries.

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include whether the Flurizan Phase 3 study design may demonstrate disease modification; the Company's use of the Natural History Staggered Start trial design and trial analysis methodology in its Flurizan Phase
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Myriad Genetics Presents Tumor Origin Technology at AACR
2. Myriad Genetics Presents Azixas Mode of Action at AACR
3. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
4. Genetics Journal Thimerosal/Autism Study the Best Science Drug Company Money Can Buy
5. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
6. ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia
7. Seattle Genetics Highlights Data on its Proprietary Antibody-Drug Conjugate Technology at AACR
8. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
9. Expression Genetics, Inc. Announces Successful Completion of Phase I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer
10. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
11. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference

Post Your Comments:
(Date:11/6/2009)...RNewswire-FirstCall/ -- Roper Industries, Inc. (...definitive agreement to acquire Verathon, Inc., a ...The Verathon Board of Directors has approved the t... regulatory approvals and closing conditions, incl...e closing to be completed in early December. ,...
(Date:11/6/2009)... Facet Solutions, Inc. announced to...us Orthopedics. The acquisition creates an undispu...llectual property and clinical experience in poste...nts suffering from lumbar spinal stenosis," stated.... "This consolidation further strengthens Facet S...
(Date:11/6/2009)...6 With his proposed health care re...ts on cutting name-brand prescription drug costs b...he "Part D" coverage gap, universally known as the...tial cost-cutting and feel it,s a promising start ...ul lobbyists want a revised program that completel...
Breaking Medicine Technology:Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Facet Solutions Acquires Archus Orthopedics 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3Palomar Successful in U S Patent Office Re Examination of Hair Removal Patent 48874 1Palomar Successful in U S Patent Office Re Examination of Hair Removal Patent 48874 2Palomar Successful in U S Patent Office Re Examination of Hair Removal Patent 48874 3Palomar Successful in U S Patent Office Re Examination of Hair Removal Patent 48874 4Palomar Successful in U S Patent Office Re Examination of Hair Removal Patent 48874 5Angel MedFlight Provides Air Medical Transportation for Accident Victim Needing Transport from France to U S 48871 1Angel MedFlight Provides Air Medical Transportation for Accident Victim Needing Transport from France to U S 48871 2Angel MedFlight Provides Air Medical Transportation for Accident Victim Needing Transport from France to U S 48871 3Economists to Declare Health Reform Key to Recovery 3B New Reports Detail Employer Health Mandate 48868 1
...vival increase in advanced non-small cell, lung ca...th paclitaxel and ci...ings include reductions in chemotherapy...and TOKYO, March 18 BioNumerik,Pharmaceuticals, I...d.,("ASKA") today announced the results of a Phase...
...rominent peer-reviewed journal highlights,findings... infection, EVANSTON, Ill., March 17 Universal h...hylococcus aureus (MRSA) using a,rapid molecular d...ing MRSA,disease, according to research published ...anston Northwestern Healthcare (ENH) researchers. ...
Other Medicine Technology:BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 2BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 3BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 4BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 5Evanston Northwestern Healthcare Researchers Explain Effects of Large-Scale, Universal MRSA Surveillance Program That Supports Expanded Intervention 2Evanston Northwestern Healthcare Researchers Explain Effects of Large-Scale, Universal MRSA Surveillance Program That Supports Expanded Intervention 3
(Date:11/7/2009)...ewswire/ -- Speaker Nancy Pelosi spoke on the Hou...able Health Care for America Act. The House will ...the Speaker,s remarks. ,, "Madam Speaker, toda...ation and for American families. For nearly a cen...phy -- as far back as Teddy Roosevelt -- have call...
(Date:11/7/2009)...ng this a "defining moment" for the American Medic...ohack, M.D., today addressed medical students and ...alty societies at the opening of the AMA,s semi-an...form will top the agenda. ,, (Logo: http://ww..., "Over the next 72 hours, this AMA House of Del...
(Date:11/7/2009)...wire/ -- The U.S. bishops November 7 urged members...tupak-Ellsworth Amendment to the health care refor...mper-Lipinski-Smith Amendment will keep in place c...nce protections in the Affordable Health Care for ...ter was signed by Cardinal Justin Rigali, chair of...
(Date:11/7/2009)... rebel, expert says , , SATURDAY, Nov. 7 (... badly if their parents expect them to, a new U.S....simply being realistic might actually contribute t... psychology professor at Wake Forest University an...s release. "Negative expectations on the part of b...
(Date:11/7/2009)...tox’ or ‘Boytox’, the new trend ... jab ‘Breastox’ – or breast boto...e, can reduce the appearance of wrinkles and lift ...ving smoother, younger-looking skin. , ...m, the UK’s largest group of cosmetic surge...
Breaking Medicine News(10 mins):Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2Health News:UK Boobs Get a Boost with 'Breastox' 2
... The following release was issued today by the Na...s after federal vaccine court ruled against three ...children, Huffington Post writers Robert F Kenne...ek, Banks, parents were awarded a lump sum of more...
...worker at a paper-recycling plant, fell through a ...as he was preparing to inspect a steam valve. Supe... degrees Fahrenheit, enveloped his legs instantly,...ft with first-, second- and third-degree burns on ...
...6 Most people accustomed to working within a mana... question the quality of their care or the cost of...charge until after a surgery when they get the bil...ings accounts (HSA) are growing in popularity. Yo...
...eb. 26 On Monday, March 2, the advertising and ...y to become "The Healthiest Company in Green Bay."...the area to beat them at that goal. , , The 30-pe...Company in Green Bay," is based on a list of key h...
... of education and cultural competence as keys to s...emy of Orthopaedic Surgeons ( http://www.aaos.o... has spent the majority of his life encouraging th...today with the Academy,s Diversity Award at its 20...
...ns aid orthopaedic surgeons in treating this commo...itis (OA) ( http://www.orthoinfo.org/topic.cfm?to...tis. It can affect any joint in the body particul... of the American Academy of Orthopaedic Surgeons ...
Other Medicine News:Health News:On the Heels of Court Ruling Denying Autism-Vaccine Link, U.S. Federal Court Declares MMR Vaccine Caused Autism in a Young Boy 2Health News:Burn rehabilitation experts at UT Southwestern outline best treatments for post-burn itching 2Health News:Burn rehabilitation experts at UT Southwestern outline best treatments for post-burn itching 3Health News:Five Steps to Improve Care and Lower the Cost of Your Surgery 2Health News:Five Steps to Improve Care and Lower the Cost of Your Surgery 3Health News:Five Steps to Improve Care and Lower the Cost of Your Surgery 4Health News:Arketype to Become Green Bay's Healthiest Company in One Year -- Wanna Bet? 2Health News:Arketype to Become Green Bay's Healthiest Company in One Year -- Wanna Bet? 3Health News:Ramon L. Jimenez, MD: A Diverse Life 2Health News:Ramon L. Jimenez, MD: A Diverse Life 3Health News:An Orthopaedic Roadmap for Osteoarthritis of the Knee 2Health News:An Orthopaedic Roadmap for Osteoarthritis of the Knee 3
...IFICATIONS Form: Granular, free-flowing powder EEO...#37;): less than or equal to 35C Remelt Point (3&#...7;): greater than or equal to 300 gm/cm 2 Moistur... equal to 0.10% DNase: Passes test RNase: Pass...
...804; 500 mg/kg sulfate (SO 4 ) ≤ 1000 mg/kg .../kg Co ≤ 5 mg/kg Cr ≤ 5 mg/kg Cu Ͱ...Mg ≤ 50 mg/kg Mn ≤ 5 mg/kg Na ≤ ...n ≤ 5 mg/kg Special grade: for molecular bio...
...804; 500 mg/kg sulfate (SO 4 ) ≤ 1000 mg/kg ...g/kg Co ≤ 5 mg/kg Cr ≤ 10 mg/kg Cu ...g Mg ≤ 5 mg/kg Mn ≤ 5 mg/kg Na ≤...Zn ≤ 5 mg/kg Special grade: for molecular bi...
Agarose, high purity, Molecular Biology Grade
Medicine Products: